ETRASIMOD IMPROVES QUALITY OF LIFE IN ADULTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 2 OASIS TRIAL AND OPEN-LABEL EXTENSION

Michael Chiorean  ¹     Severine Vermeire  ²     Julian Panés  ³     Laurent Peyrin-Biroulet  ⁴     Bruce E. Sands  ⁵     Stefan Schreiber  ⁶     Gamar Akhundova-Unadkat  ⁷     Snehal U. Naik  ⁸     Christopher J. Rabbat  ⁸     William Sandborn  ^9    
1 Swedish Medical Center, Seattle, United States
² University Hospitals Leuven, Flanders, Belgium
³ Hospital Clinic of Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain
⁴ University Hospital of Nancy, Vandœuvre-lès-Nancy, France
⁵ Icahn School of Medicine at Mount Sinai, New York, United States
⁶ University Hospital Schleswig-Holstein, Kiel University, Kiel, Germany
⁷ Arena Pharmaceuticals Development GmbH, Zug, Switzerland
⁸ Arena Pharmaceuticals, Inc., San Diego, United States
⁹ University of California San Diego, La Jolla, United States

Session
IBD (Posters)

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)